Inhibiting RHO geranylgeranylation has an unexpected outcome on inflammation

Key Points

• Inhibiting RHO geranylgeranylation alters inflammation pathways, suggesting unexpected immune responses.
• Key findings reveal significant shifts in inflammatory biomarkers during the intervention phase.
• Observational analysis revealed alterations in cellular pathways linked to inflammation and RHO modulation.
• Further understanding of RHO's role may inform future therapeutic strategies for inflammatory diseases.